Reumatologia

Revisão | Resposta a doses adicionais de vacinas contra COVID-19 em pessoas imunocomprometidas.

17 Fev, 2022 | 14:43h

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review – The Lancet Global Health

 

Comentário no Twitter

A review of the 23 studies of Covid vaccination for immunocompromised people indicates the level of responders varies with conditions. Even additional doses may not provide sufficient protection for some, requiring additional measureshttps://t.co/BjaKrJUAbO @LancetGH pic.twitter.com/EYVWAX23Ig

— Eric Topol (@EricTopol) February 15, 2022

 

---

Revisão sistemática | Eficácia clínica e imunológica das vacinas contra COVID-19 em populações imunocomprometidas.

10 Fev, 2022 | 13:08h

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review – Clinical Microbiology and Infection

---

Avanços no lúpus eritematoso sistêmico.

8 Fev, 2022 | 14:32h

New developments in systemic lupus erythematosus – Rheumatology

---

Avanços na espondilite anquilosante.

8 Fev, 2022 | 14:31h

New developments in ankylosing spondylitis—status in 2021 – Rheumatology

---

Avanços nas farmacoterapias para osteoartrite.

8 Fev, 2022 | 14:30h

New developments in osteoarthritis pharmacological therapies – Rheumatology

---

Progresso recente nos tratamentos da artrite reumatoide: uma visão geral sobre os avanços das medicações biológicas e moléculas pequenas, além das necessidades ainda não supridas.

8 Fev, 2022 | 14:29h

Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs – Rheumatology

---

Avanços na síndrome de Sjögren.

8 Fev, 2022 | 14:28h

New developments in Sjogren’s syndrome – Rheumatology

---

Recomendações EULAR para manejo de risco cardiovascular nas doenças reumáticas e musculoesqueléticas, incluindo lúpus eritematoso sistêmico e síndrome antifosfolípide.

7 Fev, 2022 | 13:43h

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome – Annals of Rheumatic Diseases

---

Critérios de classificação ACR/EULAR 2022 para poliangiíte microscópica.

4 Fev, 2022 | 17:27h

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis – Annals of Rheumatic Diseases (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

🚨 # 2022 ACR/EULAR classification criteria for Rheumatology classification criteria for microscopic polyangiitis
1️⃣sensitivity 91%
2️⃣specificity 94%https://t.co/6pPHL8JGVH pic.twitter.com/NJdrS9c6gs

— ARD & RMD Open (@ARD_BMJ) February 2, 2022

 

---

Critérios de classificação ACR/EULAR 2022 para granulomatose com poliangiíte.

4 Fev, 2022 | 17:26h

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis – Annals of Rheumatic Diseases (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

🚨 # 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis
1️⃣sensitivity 93%
2️⃣specificity 94%https://t.co/pJzZydezBB pic.twitter.com/2PafF2pbzo

— ARD & RMD Open (@ARD_BMJ) February 2, 2022

 

---